Ananda Pharma (STU:1FX) Total Liabilities: €3.35 Mil (As of Jul. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ananda Pharma Total Liabilities?

Ananda Pharma STU:1FX Total Liabilities is €3.35 Mil as of Jul. 2025. The stock has 5 warning signs investors should review.

Ananda Pharma's Total Liabilities for the quarter that ended in Jul. 2025 was €3.35 Mil.

Ananda Pharma's quarterly Total Liabilities declined from Jul. 2024 (€4.89 Mil) to Jan. 2025 (€2.99 Mil) but then increased from Jan. 2025 (€2.99 Mil) to Jul. 2025 (€3.35 Mil).

Ananda Pharma's annual Total Liabilities declined from Jan. 2023 (€6.03 Mil) to Jan. 2024 (€3.79 Mil) and declined from Jan. 2024 (€3.79 Mil) to Jan. 2025 (€2.99 Mil).

Ananda Pharma Total Liabilities Historical Data

* Premium members only.

The historical data trend for Ananda Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ananda Pharma Total Liabilities Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Total Liabilities
Get a 7-Day Free Trial 0.52 2.49 6.03 3.79 2.99

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.41 3.79 4.89 2.99 3.35

Ananda Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ananda Pharma's Total Liabilities for the fiscal year that ended in Jan. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.927+(0+0.058
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.99

Total Liabilities=Total Assets (A: Jan. 2025 )-Total Equity (A: Jan. 2025 )
=5.526-2.541
=2.99

Ananda Pharma's Total Liabilities for the quarter that ended in Jul. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.297+(0+0.057
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3.35

Total Liabilities=Total Assets (Q: Jul. 2025 )-Total Equity (Q: Jul. 2025 )
=3.695-0.341
=3.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €3.35 Mil mean?
Ananda Pharma (STU:1FX) has a Total Liabilities of €3.35 Mil as of Jul. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ananda Pharma and its competitors.
Is Ananda Pharma's Total Liabilities too high?
Ananda Pharma's current Total Liabilities is €3.35 Mil.
How does Ananda Pharma's Total Liabilities compare to ZTS and UTHR?
Ananda Pharma's Total Liabilities of €3.35 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Ananda Pharma and its competitors. Ananda Pharma's current Total Liabilities is €3.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ananda Pharma stock overvalued right now?
Ananda Pharma (STU:1FX) has a current Total Liabilities of €3.35 Mil. The current Total Liabilities is €3.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Ananda Pharma (STU:1FX), the current Total Liabilities is €3.35 Mil as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ananda Pharma Business Description

Address 60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).